Show simple item record

dc.contributor.authorMahmud, Ehtisham
dc.contributor.authorDauerman, Harold L
dc.contributor.authorMessenger, John Cen_US
dc.contributor.authorRao, Sunil Ven_US
dc.contributor.authorGrines, Cindyen_US
dc.contributor.authorMattu, Amalen_US
dc.contributor.authorKirtane, Ajay Jen_US
dc.contributor.authorJauhar, Rajiven_US
dc.contributor.authorMeraj, Perwaizen_US
dc.contributor.authorRokos, Ivan Cen_US
dc.contributor.authorRumsfeld, John Sen_US
dc.contributor.authorHenry, Timothy Den_US
dc.contributor.authorWelt, Frederick Gp
dc.date.accessioned2020-09-08T17:21:56Z
dc.date.available2020-09-08T17:21:56Z
dc.date.issued2020-09-15
dc.identifier.urihttp://hdl.handle.net/10713/13651
dc.description.abstractThe worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with this novel coronavirus. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating an ST-elevation myocardial infarction (STEMI) presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury, and the prevalence of COVID-19 disease in the U.S. population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.en_US
dc.description.urihttps://doi.org/10.1016/j.jacc.2020.04.039en_US
dc.language.isoenen_US
dc.publisherElsevier Ltd.en_US
dc.relation.ispartofJournal of the American College of Cardiologyen_US
dc.rightsCopyright © 2020 American College of Cardiology Foundation and Wiley Periodicals, Inc. Published by Elsevier Inc. All rights reserved.en_US
dc.subjectCOVID-19en_US
dc.subjectSTEMIen_US
dc.subjectacute myocardial infarctionen_US
dc.subjectemergency medical systemen_US
dc.subjectfibrinolysisen_US
dc.subjectpercutaneous coronary interventionen_US
dc.titleManagement of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)en_US
dc.typeArticleen_US
dc.typeOtheren_US
dc.identifier.doi10.1016/j.jacc.2020.04.039
dc.identifier.pmid32330544
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record